These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11273789)
1. Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics. Dicpinigaitis PV Pulm Pharmacol Ther; 2001; 14(2):93-7. PubMed ID: 11273789 [TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. Ishiura Y; Fujimura M; Yamamoto H; Ishiguro T; Ohkura N; Myou S J Investig Allergol Clin Immunol; 2009; 19(5):370-4. PubMed ID: 19862936 [TBL] [Abstract][Full Text] [Related]
3. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
5. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Khan AA; Brahim JS; Rowan JS; Dionne RA Clin Pharmacol Ther; 2002 Jul; 72(1):44-9. PubMed ID: 12152003 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579 [TBL] [Abstract][Full Text] [Related]
8. Outcome of specific COX-2 inhibition in rheumatoid arthritis. Lipsky PE; Isakson PC J Rheumatol Suppl; 1997 Jul; 49():9-14. PubMed ID: 9249645 [TBL] [Abstract][Full Text] [Related]
9. Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2. Calkin AC; Sudhir K; Honisett S; Williams MR; Dawood T; Komesaroff PA J Clin Endocrinol Metab; 2002 Nov; 87(11):5072-5. PubMed ID: 12414874 [TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Kusunoki N; Yamazaki R; Kawai S Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719 [TBL] [Abstract][Full Text] [Related]
11. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. Dilger K; Herrlinger C; Peters J; Seyberth HW; Schweer H; Klotz U J Clin Pharmacol; 2002 Sep; 42(9):985-94. PubMed ID: 12211224 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847 [TBL] [Abstract][Full Text] [Related]
13. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Werner U; Werner D; Rau T; Fromm MF; Hinz B; Brune K Clin Pharmacol Ther; 2003 Aug; 74(2):130-7. PubMed ID: 12891223 [TBL] [Abstract][Full Text] [Related]
15. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Peebles RS; Hashimoto K; Morrow JD; Dworski R; Collins RD; Hashimoto Y; Christman JW; Kang KH; Jarzecka K; Furlong J; Mitchell DB; Talati M; Graham BS; Sheller JR Am J Respir Crit Care Med; 2002 Apr; 165(8):1154-60. PubMed ID: 11956061 [TBL] [Abstract][Full Text] [Related]
17. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
18. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Rossat J; Maillard M; Nussberger J; Brunner HR; Burnier M Clin Pharmacol Ther; 1999 Jul; 66(1):76-84. PubMed ID: 10430112 [TBL] [Abstract][Full Text] [Related]
19. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062 [TBL] [Abstract][Full Text] [Related]